ProCol Vascular Bioprosthesis PMA Marks First Hancock Jaffe U.S. Approval
This article was originally published in The Gray Sheet
Executive Summary
Hancock Jaffe will pursue U.S. indications for additional sizes of its ProCol vascular bioprosthesis - a 4 mm diameter version for peripheral revascularization at the leg and a 3 mm coronary device